Recurrent miscarriage (REMIS) Study: How should data from women who do not become pregnant be handled?

Controlled Clinical Trials

Volumn 19, Issue 5, 1998, Pages 430-439

  Karrison, Theodore G ^a   Ober, Carole ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Intent to treat; Postrandomization exclusions; Power; Test size

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; INFORMATION PROCESSING; LEUKOCYTE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; BIAS (EPIDEMIOLOGY); BIRTH RATE; DATA COLLECTION; DELIVERY, OBSTETRIC; DOUBLE-BLIND METHOD; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION; IMMUNOTHERAPY; LEUKOCYTES; MALE; PREGNANCY; PREGNANCY OUTCOME; SAMPLE SIZE; SOCIAL SUPPORT; TREATMENT OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 0032189371     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(98)00019-1     Document Type: Article

References (24)

1. Beard R.W. Clinical associations with recurrent miscarriage. Beard R.W., Sharp F. Early Pregnancy Loss. Mechanisms and Treatment:1988;Springer-Verlag, New York.
2. Hill J.A., Polgar K., Harlow B.L.et al. Evidence of embryo- and trophoblast-toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol. 166:1992;1044-1052.
3. Rocklin R.E., Kitzmiller J.L., Carpenter C.B.et al. Absence of an immunologic blocking factor from the serum of women with chronic abortions. J Immunol. 107:1976;1269-1301.
4. Stimson W.H., Strachan A.F., Shepherd A. Studies on the maternal immune response to placental antigens. absence of a blocking factor from the blood of abortion-prone women Br J Obstet Gynaecol. 86:1979;41-45.
5. Unander A.M., Olding L.B. Absence of a factor blocking cellular cytotoxicity reaction in the serum of women with recurrent abortions. Br J Obstet Gynaecol. 90:1983;453-456.
6. Bertotto A., DeFelicis A.C., Mazzarino I.et al. T-cell subset distribution in chronically aborting women. Lancet. 1(8368):1984;108.
7. Virag I., Schecter E., Elgat M.et al. Lymphocyte subsets in habitual abortion. Am J Repro Immunol Microb. 12:1986;7-9.
8. Beer A.E., Semprini A.E., Xiaoyu Z.et al. Pregnancy outcome in human couples with recurrent spontaneous abortions. HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization Exper Clin Immunogen. 12:1986;7-9.
9. Ober C., van der Ven K. HLA and fertility. Hunt J.S. HLA and the Maternal-Fetal Relationship. 1996;R.G. Landes Company, Austin, TX.
10. Mowbray J.F., Liddell H., Underwood J.L.et al. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet. 1(8435):1985;941-943.
11. The Recurrent Miscarriage Immunotherapy Trialists Group Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Repro Immun. 32:1994;55-72.
12. Stray-Pedersen B., Stray-Pedersen S. The role of psychotherapy. Beard R.W., Sharp F. Early Pregnancy Loss. Mechanisms and Treatment:1988;Springer-Verlag, New York.
13. Wilcox A.J., Weinberg C.R., O'Connor J.F.et al. Incidence of early loss of pregnancy. N Engl J Med. 319:1988;189-194.
14. Snedecor G.W., Cochran W.G. Statistical Methods. 7:1980;Iowa State University Press, Ames, Iowa.
15. Lachin J.M. Introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials. 2:1981;93-113.
16. Rao C.R. Linear Statistical Inference and Its Applications. 2:1973;John Wiley & Sons, New York.
17. SAS Institute, Inc SAS Language, Reference, Version 6. 1990;SAS Institute, Cary, NC.
18. Friedman L.M., Furberg C.D., DeMets D.L. Fundamentals of Clinical Trials. 1981;John Wright, PSG, Boston.
19. Meinert C. Clinical Trials Design, Conduct, and Analysis. 1986;Oxford University Press, New York.
20. Block J.E. Interpreting studies of exercise and osteoporosis. a call for rigor Controlled Clin Trials. 18:1997;54-57.
21. Sackett D.L., Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med. 1410-1412:1979.
22. Brown B.W. The crossover experiment for clinical trials. Biometrics. 36:1980;69-79.
23. Freeman P.R. The performance of the two-stage analysis of two-treatment, two-period crossover trials. Stat Med. 8:1989;1421-1432.
24. Lachin J.M. Sample size determinations for r × c comparative trials. Biometrics. 33:1977;315-324.